Pharmaron Beijing Co., Ltd. (SHE: 300759)
China
· Delayed Price · Currency is CNY 27.91
+0.24 (0.87%)
Dec 20, 2024, 3:04 PM CST
Pharmaron Beijing Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,884 | 1,601 | 1,375 | 1,661 | 1,172 | 547.19 | Upgrade
|
| Depreciation & Amortization | 916.38 | 916.38 | 696.18 | 497.92 | 375.16 | 317.67 | Upgrade
|
| Other Amortization | 81.42 | 81.42 | 69.88 | 79.76 | 62.86 | 56.92 | Upgrade
|
| Loss (Gain) From Sale of Assets | 10.73 | 10.73 | 1.21 | 1.37 | 7.28 | 0.67 | Upgrade
|
| Asset Writedown & Restructuring Costs | -3.64 | -3.64 | -220.52 | -55.91 | 19.45 | 6.52 | Upgrade
|
| Loss (Gain) From Sale of Investments | -21.01 | -21.01 | 71.84 | -285.29 | -348.35 | -6.73 | Upgrade
|
| Other Operating Activities | -575.35 | -33.69 | 318.9 | -38.39 | 62.79 | 65.96 | Upgrade
|
| Change in Accounts Receivable | -480.1 | -480.1 | -830.63 | -295.65 | -95.35 | -278.08 | Upgrade
|
| Change in Inventory | 82.43 | 82.43 | -120.89 | -224.88 | -120.05 | -37.96 | Upgrade
|
| Change in Accounts Payable | 461.34 | 461.34 | 584.09 | 641.74 | 421.54 | 238.52 | Upgrade
|
| Change in Other Net Operating Assets | 202.22 | 202.22 | 177.17 | 67.53 | 62.46 | 11.52 | Upgrade
|
| Operating Cash Flow | 2,495 | 2,754 | 2,143 | 2,058 | 1,649 | 938.59 | Upgrade
|
| Operating Cash Flow Growth | -10.17% | 28.50% | 4.12% | 24.84% | 75.65% | 18.70% | Upgrade
|
| Capital Expenditures | -2,124 | -2,865 | -2,950 | -2,093 | -1,316 | -754.61 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.05 | 8.11 | 3.15 | 1.61 | 3.21 | 3.44 | Upgrade
|
| Cash Acquisitions | -22.63 | - | -1,022 | -1,226 | -791.52 | -59.5 | Upgrade
|
| Investment in Securities | 777.14 | 557.56 | 1,699 | -2,020 | -1,270 | -204.63 | Upgrade
|
| Other Investing Activities | 26.9 | 48.81 | 61.13 | 78.79 | 2.94 | -29.9 | Upgrade
|
| Investing Cash Flow | -1,340 | -2,251 | -2,209 | -5,258 | -3,371 | -1,045 | Upgrade
|
| Long-Term Debt Issued | - | 4,171 | 589.81 | 4,621 | 732.5 | 726.51 | Upgrade
|
| Long-Term Debt Repaid | - | -767.08 | -838.53 | -300 | -870 | -1,289 | Upgrade
|
| Net Debt Issued (Repaid) | -551.5 | 3,404 | -248.72 | 4,321 | -137.5 | -562.8 | Upgrade
|
| Issuance of Common Stock | 17.33 | 17.33 | - | - | - | 5,093 | Upgrade
|
| Repurchase of Common Stock | -0.83 | -0.83 | -393.38 | -284.06 | - | - | Upgrade
|
| Common Dividends Paid | -548.81 | -444.79 | -404.76 | -284.72 | -135.4 | -143.19 | Upgrade
|
| Other Financing Activities | -218.37 | 939.76 | -370.4 | -91.26 | -7.28 | -140.74 | Upgrade
|
| Financing Cash Flow | -1,302 | 3,915 | -1,417 | 3,661 | -280.18 | 4,246 | Upgrade
|
| Foreign Exchange Rate Adjustments | 56.64 | 11.43 | 72.99 | -45.52 | -85.67 | -4.28 | Upgrade
|
| Net Cash Flow | -91.3 | 4,429 | -1,410 | 415.78 | -2,088 | 4,135 | Upgrade
|
| Free Cash Flow | 370.77 | -111.78 | -807.04 | -34.78 | 332.77 | 183.98 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 80.87% | 22.85% | Upgrade
|
| Free Cash Flow Margin | 3.14% | -0.97% | -7.86% | -0.47% | 6.48% | 4.90% | Upgrade
|
| Free Cash Flow Per Share | 0.21 | -0.06 | -0.45 | -0.02 | 0.19 | 0.12 | Upgrade
|
| Cash Income Tax Paid | 61.62 | -54.99 | -235.22 | -22 | -34.28 | -76.56 | Upgrade
|
| Levered Free Cash Flow | -248.66 | -1,466 | -1,678 | -479.46 | 27.17 | -159.22 | Upgrade
|
| Unlevered Free Cash Flow | -97.71 | -1,352 | -1,573 | -427.54 | 42.08 | -107.68 | Upgrade
|
| Change in Net Working Capital | 103.22 | 743.17 | 608.29 | -115.35 | -219.97 | 154.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.